Delivery Order SPE2DB20D3303-SPE2DB26FY2H3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency has awarded a delivery order valued at $2,012.06 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12-year and older formulation, 0.3ML syringe) with an ultimate completion date of November 14, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 (12 years and up) vaccine in 0.3 mL syringes, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under DLA's medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,218.80 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 (12Y UP) vaccine in 0.3mL syringes. The contract was competitively awarded without set-aside designation under firm fixed-price terms, with an ultimate completion date of November 12, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,687.52 to AmerisourceBergen Drug Corp for the supply of COMIRNATY 2025-26 vaccine (12-year-old formulation) in 0.3mL syringes. This firm fixed-price, non-set-aside delivery order was awarded on October 27, 2025, with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a $10,060.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of November 6, 2025. This is a non-set-aside competitive award issued on October 16, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $6,310.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12-year and older formulation, 0.3mL) with a completion date of October 16, 2025. This non-set-aside contract was competitively awarded on September 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,270.30 on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, identified as COMIRNATY 2024-25 (12 years and up) at 0.3 milliliters, represents a single-dose vaccine supply for military healthcare operations. The contract was competitively awarded with no set-aside provisions and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.90 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on October 22, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2H3Delivery Order
The Defense Logistics Agency awarded a $2,012.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12-year formulation, 0.3 mL syringes) with a completion date of November 28, 2025. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's position as a major pharmaceutical distributor serving federal medical procurement needs. The order will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply pharmaceuticals and medical commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract reflects DLA's strategy to maintain reliable vaccine supply chains across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/5/25 |